InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Ege David S.. Director active across 1 company, notably Seres Therapeutics, Inc.. Aggregated, 7 reports have been published. History available since 5 July 2022. The latest transaction was filed on 27 October 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ege David S. is a declarant linked to Seres Therapeutics, Inc. (XNAS), with the role listed as “See Remarks” for that company. The record shows 7 filings in total, and among the sampled recent filings the period runs from 2022-07-06 to 2024-08-19, with the transaction nature listed as “Levée d'options”.